Medicine and Dentistry
Malignant Neoplasm
76%
Catheter Infection
69%
Infection
62%
Antiinfective Agent
50%
Central Venous Catheter
49%
Bloodstream Infection
42%
Hematologic Malignancy
24%
Minocycline
22%
Invasive Aspergillosis
17%
Neutropenia
16%
In Vitro
15%
Antibiotics
14%
Chlorhexidine
14%
Rifampicin
14%
Blood Culture
13%
Edetic Acid
12%
Catheter Removal
10%
Antifungal Therapy
10%
Methicillin Resistant Staphylococcus Aureus
10%
Alcohol
10%
Candidemia
9%
Procalcitonin
9%
Transplantation
9%
Hematopoietic Stem Cell Transplantation
9%
Diseases
9%
Tertiary Care
9%
Cytomegalovirus
9%
COVID-19
8%
Fungemia
8%
Antimicrobial Agent
8%
Antimicrobial Therapy
7%
Pathogen
7%
Drug Megadose
7%
Diagnosis
7%
Systemic Mycosis
7%
Voriconazole
6%
Pseudomonas aeruginosa
6%
Sulfadiazine Silver
6%
Glyceryl Trinitrate
6%
Health Care Cost
6%
Thrombosis
6%
Device Infection
6%
Bone Marrow Transplantation
6%
Infectious Disease
6%
Treatment Duration
6%
Cohort Effect
5%
Surgical Infection
5%
Staphylococcal Bacteremia
5%
Amphotericin B Lipid Complex
5%
Aspergillus
5%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Infection
59%
Hematologic Malignancy
43%
Bloodstream Infection
32%
Invasive Aspergillosis
32%
Antiinfective Agent
23%
Diseases
20%
Amphotericin B
19%
Systemic Mycosis
18%
Posaconazole
18%
Antifungal Therapy
15%
Voriconazole
14%
Procalcitonin
13%
Antibiotics
13%
Neutropenia
12%
Caspofungin
12%
Catheter Infection
12%
Vancomycin
11%
Adverse Event
11%
Methicillin-Resistant Staphylococcus Aureus
11%
Infectious Agent
10%
Minocycline
9%
Candidemia
9%
Leukemia
9%
Aspergillus
9%
Pseudomonas aeruginosa
9%
Amphotericin B Lipid Complex
9%
Linezolid
8%
Mycosis
8%
Chemotherapy
7%
Staphylococcus aureus
7%
Vancomycin-Resistant Enterococcus
7%
Human respiratory syncytial virus
7%
Candida
6%
Antifungal Agent
6%
Chlorhexidine
6%
Respiratory Syncytial Virus Infection
6%
Ethylenediaminetetraacetic Acid
6%
Febrile Neutropenia
6%
Dalfopristin Plus Quinupristin
6%
Itraconazole
6%
Staphylococcus Epidermidis
5%
Rifampicin
5%
Ribavirin
5%
Hepatitis C Virus
5%
Staphylococcal Bacteremia
5%
Imipenem
5%
Mortality Rate
5%
Solid Malignant Neoplasm
5%
Proadrenomedullin
5%
Keyphrases
Cancer Patients
53%
Central Venous Catheter
34%
In Cancer
32%
Catheter-related Bloodstream Infection (CRBSI)
28%
Catheter
27%
Patients with Cancer
26%
Hematological Malignancies
26%
Invasive Aspergillosis
22%
Minocycline
21%
Catheter-related
20%
Bloodstream Infection
20%
Catheter-related Infections
17%
Antimicrobial
16%
Catheter Lock
16%
Risk Factors
15%
Bacteremia
15%
Central Line-associated Bloodstream Infection (CLABSI)
13%
Cancer Center
11%
Vancomycin-resistant Enterococci
11%
Biofilm
11%
Neutropenia
10%
Catheter Removal
10%
Antimicrobial Lock Therapy
10%
Ethanol
10%
Voriconazole
10%
Procalcitonin
9%
Staphylococcus Aureus Bacteremia
9%
Tertiary Care
9%
Liposomal Amphotericin B
8%
Posaconazole
8%
Antibiotics
8%
Blood Culture
8%
Vascular Catheter
8%
Antifungal Therapy
8%
Rifampin
8%
Leukemia
8%
Candidemia
8%
Intravascular Infection
8%
Staphylococcus Aureus
8%
Fungemia
7%
Invasive Fungal Infection
7%
Caspofungin
7%
Quinupristin-dalfopristin
7%
Salvage Therapy
7%
Solid Tumors
7%
Invasive Pulmonary Aspergillosis
7%
Highly Effective
7%
Vancomycin
7%
Candida Auris
6%
Clinical Outcomes
6%